FDA
-
-
-
-
-
-
-
FDA approves Freenome's blood-based colorectal cancer screening test
-
-
-
-
-
-
-
American Cancer Society reaffirms Abbott colorectal screening tests
-
-
-
-
-
-
-
Abbott presents positive 12-month data on atrial fibrillation devices
-
-
-
-
-
-
-
Abbott's Voltâ„¢ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation
-
-
-
-
-
-
-
Evercore ISI on Boston Scientific (BSX) Read-through: 'This should be a positive for ABT & MDT'
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Abbott Labs (ABT) Following CE Mark news
-
-
-
-
-
-
-
Cagent Vascular Appoints Paul Wilson as Chief Commercial Officer to Drive Growth and Market Expansion
-
330,175 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

